尿管ステントの世界市場（2025年～2033年）

世界の尿管ステントの市場規模は、2024年に5億2,145万米ドルに達し、2033年には8億5,024万米ドルに達すると予測され、予測期間2025年～2033年のCAGRは5.8%で成長すると予測されています。

尿管ステントは、腎臓から膀胱に尿を送る尿管に留置される細く柔軟なチューブです。尿管ステントの主な機能は、尿の流れを妨げる閉塞を予防または治療することであり、この閉塞は腎結石、腫瘍、狭窄など多くの医学的問題によって引き起こされます。尿管ステントは、尿管が腎臓から膀胱へ尿が適切に通過するのに十分な幅を保つように設計されています。閉塞がある場合によく使用されます。

尿管ステントの需要増加は、予測期間中の市場を牽引する要因です。このような需要の増加は、泌尿器科的問題の有病率の上昇、高齢者人口の増加、ステント技術の進歩など、相互に関連するさまざまな原因と関連付けることができます。これらすべての要因が相まって尿管ステントの需要が増加し、市場を牽引しています。

市場力学：

促進要因と抑制要因

尿管ステント需要の増加

尿管ステントに対する需要の増加は、世界の尿管ステント市場の成長において重要な要因となることが予想されます。尿管ステントの世界市場は、腎臓関連疾患の増加、投資の増大、技術の進歩により、大きく拡大する見込みです。腎臓関連疾患の罹患率の増加は、尿管ステントの需要増加に大きな影響を与えています。

例えば、米国国立衛生研究所によると、慢性腎臓病は世界人口の10％以上、すなわち全世界で8億人以上が罹患する進行性の疾患です。また、全米腎臓財団によれば、世界で200万人以上が透析や腎移植による治療を受けていますが、この推計は生存のために実際に治療を必要とする人の10％に過ぎない可能性があります。このような問題がますます一般的になるにつれて、尿管ステント留置術のような効果的な治療に対する需要が高まっています。

最近の動向では、尿管ステントの研究開発および製造のために多くの資金や投資が行われています。例えば、2024年11月、タミル・ナードゥ州政府と米国に本社を置くルーブリゾールは覚書に調印しました。この提携には約20億インドルピーが投じられ、尿管ステント、神経血管・心血管治療、静脈カテーテル、血液透析チューブ、中心静脈カテーテルなどの主要用途向けに高品質の医療用チューブが製造されました。尿管ステントの需要増に対応するため、投資の増加、尿管ステントの生産量の増加が市場を牽引しています。

ステント除去後の合併症リスクの高さ

ステント除去後の合併症リスクの高さなどが、尿管ステントの世界市場を妨げると予想されます。感染症、血尿、急性疼痛などの合併症は、患者のQOLに大きな影響を与える可能性があり、これらのデバイスの使用に対する消極的な姿勢を強めています。尿意切迫感、頻尿、不快感の増加などの刺激性排尿症状は、ステント除去の最も一般的な結果の1つです。さらに、抜去後に尿路感染症や長引く出血などのより重篤な合併症が起こり、追加の外科的治療が必要になることもあります。このような潜在的な結果を恐れるあまり、患者は不安になり、泌尿器科医はステント留置を第一選択の治療法として提案することに消極的になる可能性があります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
  • 尿管ステントの需要増加
• 抑制要因
  • ステント除去後の高い合併症リスク
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• 償還分析
• 特許分析
• SWOT分析
• DMIの見解

第6章 製品タイプ別

• マルチループ
• オープンエンドステント
• クローズドエンドステント
• ダブルピグテールステント

第7章 材料別

• 金属ステント
• シリコンステント
• ハイブリッドステント
• ポリウレタンステント
• その他

第8章 用途別

• 腎臓結石
• 腎臓移植
• 腫瘍
• 尿失禁
• その他

第9章 エンドユーザー別

• 病院と診療所
• 外来手術センター
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• 中東・アフリカ

第11章 競合情勢

• 競合シナリオ
• 市況・シェア分析
• M&A分析

第12章 企業プロファイル

• Boston Scientific Corporation
  • 会社概要
  • 製品ポートフォリオと概要
  • 財務概要
  • 主な発展
• B. Braun Holding GmbH & Co. KG
• Cook Group Incorporated
• Coloplast Ltd.
• BD
• Medline Industries, Inc.
• Allium Medical Solutions Ltd
• Pnn Medical A/S
• Teleflex Incorporated
• Olympus Corporation

第13章 付録

The Global Ureteral Stents Market reached US$ 521.45 Million in 2024 and is expected to reach US$ 850.24 Million by 2033, growing at a CAGR of 5.8% during the forecast period 2025-2033.

A ureteral stent is a thin, flexible tube placed in the ureter, which transfers urine from the kidneys to the bladder. Its major function is to prevent or treat obstructions that interfere with urine flow, which can be caused by a number of medical problems such as kidney stones, tumors, or strictures. Ureteral stents are designed to keep the ureter wide enough for urine to pass properly from the kidney to the bladder. They are frequently employed in situations where there is a blockage.

The increasing demand for ureteral stents is the driving factor that drives the market over the forecast period. This increase in demand can be linked to various interrelated causes, including the rising prevalence of urological problems, the increasing geriatric population, and advances in stent technology. All these factors together increase the demand for ureteral stents and it drives the market.

Market Dynamics: Drivers & Restraints

Increasing demand for ureteral stents

The increasing demand for ureteral stents is expected to be a significant factor in the growth of the global ureteral stents market. The global ureteral stents market is poised for significant expansion, owing to the rising number of kidney-related disorders, increasing investments, and technological advancements. The rising incidence of kidney-related conditions has a substantial impact on the increasing demand for ureteral stents.

For instance, according to the National Institute of Health, chronic kidney disease is a progressive disorder that affects more than 10% of the world's population, or over 800 million people across the globe. Moreover, according to the National Kidney Foundation, over 2 million people worldwide are receiving treatment with dialysis or a kidney transplant to stay alive, however, this estimate may only represent 10% of people who actually need treatment for their survival. As these problems become increasingly common, the demand for effective treatments, such as ureteral stenting, has increased.

In recent times, many funds and investments have been made for research, development, and manufacture of ureteral stents. For instance, in November 2024, The Tamil Nadu government and Lubrizol, based in the United States, signed a Memorandum of Understanding (MoU). The partnership, which cost approximately INR 200 crore, generated high-quality medical tubing for key applications such as ureteral stents, neurovascular and cardiovascular treatments, intravenous catheters, hemodialysis tubes, and central venous catheters. The increased investments, increase the production volume of the ureteral stents to meet the increasing demand for ureteral stents and it drives the market.

High risk of complications post-stent removal

Factors such as the high risk of complications post-stent removal are expected to hamper the global ureteral stents market. Complications such as infection, hematuria, and acute pain can have a major impact on patient quality of life, increasing reluctance to use these devices. Irritative voiding symptoms, such as increased urine urgency, frequency, and discomfort, are one of the most prevalent consequences of stent removal. Furthermore, more serious complications such as urinary tract infections and prolonged bleeding may occur following removal, necessitating additional surgical treatments. Fear of these potential consequences can cause patients to become anxious, and urologists might become reluctant to suggest stenting as a first-line treatment option.

Segment Analysis

The Global Ureteral Stents Market is segmented based on Product Type, Material, Application, End-User, And Region.

Double pigtail stents segment is expected to dominate the global ureteral stents market share

The double pigtail stents segment is anticipated to dominate the global ureteral stents market owing to their unique design, featuring coiled ends and technological advancements.

These stents are distinguished by their unique shape, which includes coiled ends that assist anchor the stent within the urinary tract, successfully avoiding migration and ensuring solid placement. This design not only reduces the risk of issues associated with stent displacement but also allows for better compliance with the anatomical structure of the urinary system, thereby improving patient comfort during use. This unique shape of the stent makes it user-friendly for the patients and increases the demand for the double pigtail stents making this the most dominating segment in the global ureteral stents market.

Recent technological advancements and launches have boosted the acceptance of double pigtail stents. For instance, in December 2024, The RELIEF ureteral stent was approved as the first and only stent for the prevention of vesicoureteral reflux, which is a major source of patient discomfort. Technological improvements and recent launches such as RELIEF ureteral stents have aided the development of minimally invasive insertion techniques for double pigtail stents. These procedures not only improve the simplicity of implantation but also minimize recuperation time for patients, increasing their acceptance in medical facilities and making them the most dominating segment in the global ureteral stents market.

Geographical Analysis

North America is expected to hold a significant position in the global ureteral stents market share

North America is expected to hold a significant portion of the global ureteral stents market. North America will likely account for a significant share of the global ureteral stents market, owing to its rising number of kidney-related disorders, increasing healthcare investments, advanced healthcare infrastructure, and technological advancements. One of the primary drivers of this demand in North America is the single number of kidney-related disorders.

For instance, according to the American Kidney Fund, more than 35.5 million Americans suffer from kidney disease. An estimated 808,000 Americans suffer from kidney failure. More than 557,000 Americans are on dialysis. Kidney disease is spreading at an alarming rate. It currently affects more than one in every seven (14% of American adults). In 2021, more than 135,000 Americans were diagnosed with kidney failure. Nine out of 10 individuals with renal disease were unaware of their status, and one-third of those with severely impaired kidney function were also unaware. Due to the increasing number of kidney-related disorders, the need for ureteral stents is increasing which helps ensure proper flow of urine through the ureter, this increases the demand for ureteral stents and drives the market in North America.

Asia Pacific is growing at the fastest pace in the global ureteral stents market

The Asia Pacific region is emerging as the fastest-growing market for ureteral stents, owing to a rising prevalence of urological disorders, increasing healthcare investments, and technological advancements. The increasing number of kidney-related disorders and renal replacement therapies are the primary reasons for the upsurge and growth of the market in the Asia Pacific region. For instance, the estimated prevalence of CKD is 800 per million people (pmp), while the incidence of end-stage renal disease (ESRD) is 150-200 pmp. Diabetic nephropathy is the leading cause of chronic kidney disease in population-based research. In India, nearly 18,000-20,000 patients (10% of new ESRD cases) receive renal replacement therapy, with over 172 transplant centers, the majority of which are privately run and located in South India. Each year, nearly 3,500 transplants are performed, with approximately 700 cadaver donors. Due to the increasing number of kidney-related disorders, the improper flow of urine is increasing which increases the demand for the ureteral stents market in the Asia Pacific region.

Competitive Landscape

The major global players in the global ureteral stents market include Boston Scientific Corporation, B. Braun Holding GmbH & Co. KG, Cook Group Incorporated, Coloplast Ltd., BD, Medline Industries, Inc., Allium Medical Solutions Ltd, Pnn Medical A/S, Teleflex Incorporated, Olympus Corporation among others.

Emerging Players

Mitra Industries, InVivo Bionics, and ZygoFix among others

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global ureteral stents market report delivers a detailed analysis with 70+ key tables, more than 60 visually impactful figures, and 250 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Material
• 3.3. Snippet by Application
• 3.4. Snippet by End-User
• 3.5. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
  • 4.1.2. Increasing Demand for Ureteral Stents
• 4.2. Restraints
  • 4.2.1. High Risk of Complications Post-stent Removal
  • 4.2.2. Opportunity
  • 4.2.3. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Reimbursement Analysis
• 5.6. Patent Analysis
• 5.7. SWOT Analysis
• 5.8. DMI Opinion

6. By Product Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 6.1.2. Market Attractiveness Index, By Product Type
• 6.2. Multiloop*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Open-end stents
• 6.4. Closed-end stents
• 6.5. Double pigtail stents

7. By Material

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 7.1.2. Market Attractiveness Index, By Material
• 7.2. Metal stents*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Silicone stents
• 7.4. Hybrid stents
• 7.5. Polyurethane stents
• 7.6. Others

8. By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. Kidney stones*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Kidney transplantation
• 8.4. Tumors
• 8.5. Urinary incontinence
• 8.6. Others

9. By End User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.1.2. Market Attractiveness Index, By End User
• 9.2. Hospitals and Clinics*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Ambulatory Surgical Centers
• 9.4. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.7.1. The U.S.
    • 10.2.7.2. Canada
    • 10.2.7.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.7.1. Germany
    • 10.3.7.2. UK
    • 10.3.7.3. France
    • 10.3.7.4. Italy
    • 10.3.7.5. Spain
    • 10.3.7.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.7.1. Brazil
    • 10.4.7.2. Argentina
    • 10.4.7.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.7.1. China
    • 10.5.7.2. India
    • 10.5.7.3. Japan
    • 10.5.7.4. South Korea
    • 10.5.7.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Boston Scientific Corporation*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. B. Braun Holding GmbH & Co. KG
• 12.3. Cook Group Incorporated
• 12.4. Coloplast Ltd.
• 12.5. BD
• 12.6. Medline Industries, Inc.
• 12.7. Allium Medical Solutions Ltd
• 12.8. Pnn Medical A/S
• 12.9. Teleflex Incorporated
• 12.10. Olympus Corporation

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us